Recent studies have revealed the clinical usefulness of central blood pressure (BP) as an index of risk for cardiovascular disease. The arterial pulse waveform is the sum of the forward pressure wave generated by left ventricular ejection and a backward propagating wave that is subsequently reflected from the peripheral site, and the time point at which these forward and backward propagating waves merge and the amplitude of the reflected (backward) wave affect the level of central BP. The augmentation index (AIx) has been proposed as a measure of the wave reflection, and its clinical usefulness has also been evaluated. In the process, the non-linear relationship between age and AIx, the prognostic value of AIx, and the various effects of antihypertensive drugs on AIx have been shown. However, the clinical usefulness of AIx has not been established, and several questions about its use remain. Future studies will be needed to address these questions, and may contribute to important changes in the management of cardiovascular disease. In this review, we present recent findings on the AIx and discuss the role of this parameter in clinical practice.
Introduction
For over a century the technique of brachial blood pressure (BP) measurement developed by Riva-Rocci and Korotkoff has provided most of the data on hypertension diagnosis and treatment. Many observational epidemiology studies and clinical trials have shown a strong association between brachial BP and adverse cardiovascular events, and the efficacy of antihypertensive agents to reduce the risk of cardiovascular events by lowering brachial BP. Recent studies, however, have shown that central BP (aortic BP) estimated by pulse wave analysis correlates more closely with cardiovascular events than brachial BP [Roman et al. 2007; Williams et al. 2006] , and recent guidelines have also pointed out the potential usefulness of central BP and pulse wave analysis [Mancia et al. 2007; Guidelines Committee, 2003 ].
The arterial pulse waveform is the sum of the forward pressure wave generated by left ventricular ejection and a reflected wave created by the impedance mismatch along the arterial tree. During the generation of this waveform, the time point at which the forward and reflected propagating waves merge and the amplitude of the reflected wave affect the level of central BP. The Correspondence to: augmentation index (AIx) has been proposed as a measure of the wave reflection, and has also been shown to be associated with cardiovascular diseases. In this review, we present recent findings on the AIx and discuss the role of this parameter in clinical practice.
Definition of the augmentation index
The arterial pulse waveform is the sum of the forward pressure wave and the backward propagating wave that is subsequently reflected from the peripheral site. Murgo et al. [1980] first described the wave contour classification scheme and the contribution of reflected waves to the arterial pressure waveform.Years later, Kelly et al. [1989] simplified and formalized the classification and defined AIx as the ratio of the central augmented pressure to the central pulse pressure (Figure 1a ). On the other hand, recent studies have defined peripheral (radial) artery AIx as the ratio of the amplitude of the late systolic peak to the amplitude of the early systolic peak (Figure 1b ). Both of these definitions emphasize the importance of the assessment of late systolic pressure.
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Measurements of the augmentation index
Although AIx is ideally calculated based on the aortic pulse wave measured directly near the heart, such direct measurement is invasive and cannot be performed routinely. Therefore, the non-invasive technique of applanation tonometry has been increasingly used to acquire comparable data. At the present time, there are three major procedures for measuring AIx using applanation tonometry.
AIx derived from the carotid artery, which is near the heart, correlates reasonably well with aortic AIx measured invasively by a micromanometertipped catheter, although the carotid AIx is consistently lower than aortic AIx [Chen et al. 1996 ]. This procedure is a reasonable choice for evaluating the central AIx, but it requires technical expertise and can be uncomfortable for patients. Furthermore, application of applanation tonometry to the carotid artery is inadequate for patients with major atherosclerotic plaques or calcified arteries.
For this reason, a second method is now widely used to estimate central AIx: the synthesized central arterial pulse wave derived form radial artery applanation by using a generated transfer function (TF). Although several studies have justified the application of this procedure [Sharman et al. 2006; Gallagher et al. 2004; Pauca et al. 2001; Fetics et al. 1999; Chen et al. 1997; Karamanoglou et al. 1993] , it should be noted that there are no large clinical studies validating its efficacy, and some researchers have questioned its reliability [Hope et al. 2003; Smulyan et al. 2003; Cameron et al. 1998 ]. Moreover, this procedure has been suggested to be insufficient for the assessment of central AIx [Hope et al. 2003; Chen et al. 1997 ]. The strengths and weaknesses of this procedure have been well summarized previously [Papaioannou et al. 2006; Davies and Struthers, 2003 ].
Based on these findings, a third method has been proposed, in which a radial AIx measurement is obtained directly from the radial artery [Hope et al. 2004; Millasseau et al. 2003 ]. Takazawa et al. [2007] showed significant correlations between invasively measured aortic AIx and radial AIx. In addition, the radial AIx has also been demonstrated to be strongly associated with the carotid AIx Sugawara et al. 2007; Segers et al. 2005 ] and the TF-based central AIx [Segers et al. 2005; Filipovsky et al. 2005; Kohara et al. 2005 ].
To evaluate the clinical utility of AIx, several studies have investigated the intra-and interobserver reproducibility of AIx in various populations. Good reproducibility of carotid AIx has been shown in healthy subjects [Liang et al. 1998 ], hypertensive patients [Matsui et al. 2004] , and patients with end-stage renal disease [London et al. 1994 ]. The reproducibility of TF-based central AIx has also been verified in healthy subjects [Papaioannou et al. 2007; Filipovsky et al. 2000 ], patients with cardiovascular risk factors (hypertension or diabetes) [Wilkinson et al. 1998 ], and patients with chronic renal failure [Savage et al. 2002] . Recently, peripheral AIx was also reported to show good reproducibility [Papaioannou et al. 2007 ], although the sample size was small (n = 22) and the evidence was limited to healthy subjects. Therefore, the reproducibility of peripheral AIx, and especially radial AIx, should be investigated further in various large populations.
At present we cannot state which of these procedures is the most effective for measuring AIx. Further studies will be needed to address this question. Of course, the prognostic value of each index (carotid AIx, TF-based central AIx, and radial AIx) for cardiovascular events should also be assessed.
Determinants of the augmentation index
AIx is influenced by various factors. The arrival time of the pulse wave reflection is considered one of the major determinants of AIx. For example, arterial stiffening contributes to an Review increase in pulse wave velocity and then causes an early return of the reflected wave [Protogerou and Safar, 2007] ; body height represents the distance to the major reflecting sites [London et al. 1992] ; and higher heart rate leads to shorter duration of ejection and a delayed arrival of the reflected wave in the cardiac cycle [Wilkinson et al. 2002; Wilkinson et al. 2000 ].
The properties of peripheral muscular arteries and arterioles are also proposed to affect AIx by changing the amplitude of the reflected wave. Thus vasodilators, which relax the peripheral arteries and arterioles, are thought to decrease the amplitude of the reflected wave. Moreover, we previously reported that orthostatic increase in AIx was positively associated with exaggerated orthostatic BP increase (i.e., orthostatic hypertension) [Hoshide et al. 2005 ]. Based on this study, we consider that, in patients with orthostatic hypertension, postural change can induce an excessive increase in vascular tonus and thereby a high amplitude of the reflected wave.
Moreover, left ventricular contractility has been proposed as a major determinant of AIx, although previous studies have reported conflicting results. Some studies have shown a significant decrease in AIx among patients with impaired left ventricular contractility [Weber et al. 2007; Tartiere et al. 2006; Mitchell et al. 2001 ], while others have not [Curtis et al. 2007] . Further investigations will be needed to clarify this relationship.
Effect of age and gender on the augmentation index
Aging is one of the most powerful risk factors for cardiovascular disease, and contributes to the progression of arterial stiffness. AIx is partly affected by the velocity of the reflected wave, and numerous studies have shown a positive association between age and AIx. However, recent studies have evaluated this association in detail and have reported that AIx increases steeply with age in younger subjects, increases more gradually in subjects aged 50 to 60 years, and thereafter reaches a plateau [Fantin et al. 2007; Wojciechowska et al. 2006; McEniery et al. 2005; Mitchell et al. 2004] (Figure 2 ). Thus it is suggested that the clinical usefulness of AIx might be more prominent in younger individuals [McEniery et al. 2005 ]. (In Figure 2b , note that the clear difference in the progression line of carotid AIx between the two studies is attributable to a difference in the study AIx (%)
Relationship between age and carotid AIx is described in 521 normal American subjects (Mitchell et al. 2004 ; solid lines) and 302 normal U.K.subjects (Fantin et al. 2007 ; dash lines). AIx was calculated as the ratio of the augmented pressure to the pulse pressure. AIx, augmentation index.
Relationship between age and radial AIx is described in 632 normal Japanese subjects (Kohara et al. 2005) . AIx was caluculated as the ratio of the ratio of the amplitude of the late systolic peak to the amplitude of the early systolic peak. AIx, augmentation index. One possible mechanism of the lack of increase in AIx in elderly subjects is the distal shift of the effective reflecting site. With age, aortic stiffness increases markedly, while peripheral arterial stiffness shows little change. This unbalanced increase of arterial stiffness diminishes the impedance mismatch between the central and peripheral arteries, and moves the major effective reflecting site toward the periphery.
Another possibility is that AIx, because it represents the ratio of the augmented pressure to the pulse pressure, underestimates the change of vascular properties. That is, the clinical usefulness of AIx may be low in elderly subjects because of their higher pulse pressure. In fact, the age-related increase in augmented pressure has been shown to be linear in both young and elderly subjects [Fantin et al. 2007; McEniery et al. 2005 ]. However, there have been only a few studies evaluating the prognostic value of augmentation pressure. Further investigations will be needed to compare the clinical efficacy of augmentation pressure and AIx as measures of the wave reflection.
It is generally accepted that AIx is higher in women than in men despite the fact that cardiovascular risk is greater in men. The shorter height in women, which results in a closer proximity of the reflecting site to the heart, is considered to account for at least part of this gender difference. But several studies have reported that this difference remained statistically significant even after adjusting for height [Fantin et al. 2007; Kohara et al. 2005; McEniery et al. 2005; Mitchell et al. 2004; Gatzka et al. 2001] . Thus there may be other unknown mechanisms that contribute to the gender difference of AIx.
As shown above, we cannot ignore the effect of age and gender on AIx. Therefore, the thresholds of AIx must be adjusted for age, and be determined separately by gender. Higher AIx has also been shown to be associated with target organ damage (Table 2) . Specifically, AIx has been positively associated with left ventricular hypertrophy in normotensive subjects [Saba et al. 1993 ], hemodialysis patients [Marchais et al. 1993] , and essential hypertensive patients [Hashimoto et al. 2006 ]. Aortic atherosclerosis has also been shown to be Table 2 . Cross-sectional studies indicated the significant association between AIx and TOD.
Predictive value of the augmentation index for cardiovascular disease
Review
Author (year)
Study population (n) Age Procedure TOD Saba (1993) Normotensive subjects (67) 47 y Carotid AIx LV mass index Marchais (1993) ESRD patients 20-68 y Carotid AIx LV mass index (44) Liang (1998) Healthy volunteers 47 y Carotid AIx Carotid IMT (50) Hayashi (2002) Patients undergoing CAG 35-78 y Invasive aortic AIx CAD (190) Ravikumar (2002) Diabetic subjects (50) 54 y TF-based central AIx Carotid IMT Non-diabetic subjects (50) 54 y Tsioufis (2003) Hypertensive patients 54 y Carotid AIx UAE (130) Weber (2004) Patients undergoing CAG 64/54 y* TF-based central AIx CAD (465) Rema (2004) Diabetic subjects 54/52 y** TF-based central AIx Retinopathy (600) Hashimoto (2006) Hypertensive patients 56 y Radial AIx LV mass index (77) Qureshi (2007) Patients undergoing TEE 61 y TF-based central AIx maximal aorta IMT (81) *mean age of patients with / without CAD. **mean age of patients with / without retinopathy. AIx, augmentation index; TOD, target organ damage; ESRD, end-stage renal disease; CAG, coronary angiography; TEE, transesophageal echocardiography TF, transfer function; LV, left ventricular; IMT, intima-media thickness; CAD, coronary artery disease; UAE, urinary albumin excretion.
correlated to higher AIx [Qureshi et al. 2007; Liang et al. 1998 ], while Ravikumar et al. [2002] reported a significant relationship between AIx and carotid atherosclerosis both in their whole cohort and in a nondiabetic subset, but not in a diabetic subset. Furthermore, not only aortic AIx measured invasively but also TF-based central AIx have been correlated to the incidence and the severity of coronary artery disease [Weber et al. 2004; Hayashi et al. 2002] . Additionally, the positive association of AIx with urinary albumin excretion [Tsioufis et al. 2003 ] and diabetic retinopathy [Rema et al. 2004 ] may represent a close relationship between AIx and microvascular damages. On the other hand, some studies have found no significant correlations between AIx and target organ damages such as atherosclerosis [Eldrup et al. 2006; Saba et al. 1993] , left ventricular hypertrophy [Deague et al. 2001] , or the incidence of transient myocardial ischemia [Baulmann et al. 2006 ]. Therefore, the usefulness of AIx as a marker of target organ damage must also be confirmed further in the future.
Pulse wave analysis can also be used to estimate central BP. Recent reports have suggested the superiority of central BP to brachial BP as a guide to antihypertensive therapy [Williams et al. 2006 ] and a predictor of clinical outcomes [Roman et al. 2007; Safar et al. 2002] . Conversely, Dart et al. [2007] could not find any clinical benefit in assessing central BP in addition to brachial BP. At present, the prognostic and clinical value of using central BP instead of brachial BP has not been fully established and needs to be further evaluated in large-scale observational and interventional studies.
Effect of non-pharmacological interventions on the augmentation index
Several studies have evaluated the effects of nonpharmacological interventions on AIx. Seals et al. [2001] reported that dietary sodium restriction contributed to a significant reduction in carotid AIx. Endurance exercise has also been shown to have a beneficial effect on AIx [Edwards et al. 2004; Tanaka et al. 1998; Vaitkevicius et al. 1993 ], but strength training (e.g., bench pressing) was AIx, augmentation index; ACEs, angiotensin-converting-enzyme inhibitors; ARBs, angiotensin receptor blockers; CCBs, calcium channel blockers; TF, transfer function; NS, not significant. *AIx was calculated as the amplitude of the late systolic peak to the amplitude of the early systolic peak.
found to increase carotid AIx [Cortez-Cooper et al. 2005] .
Habitual smoking is a major cardiovascular risk factor, and a positive relationship between smoking status and AIx has been suggested [Jatoi et al. 2007; Rehill et al. 2006 ]. Furthermore, duration of smoking cessation has been positively and linearly associated with the reduction of AIx in former smokers [Jatoi et al. 2007 ]. On the other hand, the findings in regard to the effect of alcohol consumption on AIx are controversial [van Trijp et al. 2005a; van Trijp et al. 2005b; Sierksma et al. 2004; Mahmud and Feely, 2002a] , and the efficacy of temperance has not yet been evaluated.
Effect of pharmacological interventions on the augmentation index
As described above, the management of central BP is expected to play an important role in clinical practice. AIx is considered to be one of the major determinants of central BP, and several studies have evaluated the effects of various pharmacological agents on AIx. The effects of different antihypertensive drugs on AIx (and central BP) have been shown to vary, although all these agents achieve the same degree of brachial BP reduction (Table 3) . For example, angiotensinconverting-enzyme inhibitors (ACEs) [Jiang et al. 2007; Mahmud and Feely, 2002b; London et al. 1994] , angiotensin receptor blockers (ARBs) [Dhakam et al. 2006; Klingbeil et al. 2002; Mahmud and Feely, 2002b] , calcium channel blockers (CCBs) [London et al. 1994] , and nitrates [Stokes et al. 2003; Kelly et al. 2001] can decrease AIx. On the other hand, diuretic agents appear not to change AIx [Jiang et al. 2007; Klingbeil et al. 2002] and β-blockers actually increase AIx [Dhakam et al. 2006; Asmar et al. 2001] .
Interestingly, the combination therapy of ACEs and ARBs decreased AIx significantly compared to monotherapy, in spite of the lack of a remarkable dose-response relationship [Mahmud and Feely, 2002b] . Moreover, isosorbide mononitrate was shown to decrease AIx even in patients who were receiving either ACEs or ARBs [Stokes et al. 2003 ]. These studies have suggested that these agents might act in a complementary way to decrease AIx. Future researches should evaluate the effects of combinations of different classes of antihypertensive drugs on AIx and central BP.
The effects of the other vasoactive agents on AIx have also been evaluated in several studies. For example, insulin infusion has been verified to decrease AIx [Tamminen et al. 2003; Westerbacka et al. 1999] . Statins have also been Review shown to reduce AIx [Efrati et al. 2007; Leslie et al. 2004; Van Doornum et al. 2004] , and this effect was found to be independent of the change in LDL cholesterol [Efrati et al. 2007 ]. Furthermore, some studies have reported the efficacy of fenofibrate, pioglitazone [Ryan et al. 2007 ], or alagebrium (advanced glycation endproduct crosslink breaker) [Zieman et al. 2007] on AIx, although the evidence of such effects is still insufficient and further researches will be needed to confirm them.
Moreover, the clinical benefit of decreasing AIx has not been fully elucidated. Hashimoto et al. [2007] reported that pharmacological reduction of radial AIx contributed to a reduction in left ventricular mass in hypertensive patients. Future studies should also be performed to confirm and extend their observations.
Conclusion
There is mounting evidence to suggest that central BP correlates more closely with cardiovascular events than brachial BP, and AIx is one of the key factors to determine central BP. Although it is widely expected that AIx will prove clinically useful, the actual value of this measurement has not been established yet. Furthermore, several questions remain to be addressed. 
